(AOF) – The Equasens Group, health software publisher, announces the acquisition of a majority stake, up to 70%, in the capital of the start-up Digipharmacie. The acquisition of a majority stake in Digipharmacie by Equasens is an important step in the digital transformation of health. It allows the two companies to offer a complete solution, in response to the obligation to receive electronic invoices planned for September 1, 2026.
The cooperation between the two companies will make it possible to consider extended functions to further simplify and secure the administrative work of pharmacists. It will also make it possible to extend the model to other health professionals.
Based in Ile-de-France and created in 2019, Digipharmacie is a pure player in the field of digitalization of pharmacy supplier invoices.
AOF – LEARN MORE
Find out more about the IT / ESN sector (digital service companies)
Moving forward in generative AI
Digital companies have already started to adapt their offers and practices to this development, which combines ChatGPT and information systems. The most developed use cases concern call centers with the intervention of chatbots or in marketing, to generate text or images automatically. The potential is enormous and Accenture France aims to achieve 30% of its activity with the data & AI niche by 2025. World market leader, Accenture has announced $3 billion in investment over three years in this area, with a doubling in the number of dedicated employees to reach 80,000 (out of 738,000 in total). As for the French leader in the sector, Capgemini, it is targeting an investment of 2 billion euros over the next three years, and 60,000 specialized employees (out of 360,000 currently).
Artificial intelligence now regulated in Europe
An attempt was made to find a balance between the desire to protect the fundamental rights of citizens and the desire not to restrict the development of European start-ups. The French and German associations of digital companies, Numeum and Bitkom, had also called for a European regulation on artificial intelligence (AI Act) favorable to innovation for AI in Europe and without overly restrictive rules, particularly for generative AI. The European approach is to impose obligations for high-risk AI systems, rated from low to unacceptable. For the regulation of generative AI (ChatGPT type systems), the EU has established stronger requirements for the most powerful models.